AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26154249 — intervention group
Group type: COMPARATOR
Intervention: Instructor-regulated learning (IRL)
Number of subjects: 40
Study 23307544 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-enhancing drugs
Number of subjects: 2569
Study 21590281 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimonabant (CB(1) receptor antagonist) co-administered with ketamine
Number of subjects: 24
Study 21590281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 18499880 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide oral solution 2 mg t.i.d.
Number of subjects: 63
Study 18499880 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide tablets 5 mg t.i.d.
Number of subjects: 63
Study 18499880 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 16458628 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy‐assisted vaginal hysterectomy with bilateral oophorectomy (LAVHO)
Number of subjects: 48
Study 16458628 — intervention group
Group type: COMPARATOR
Intervention: Vaginal hysterectomy with bilateral oophorectomy without laparoscopic assistance (VHO)
Number of subjects: 48
Study 16458628 — intervention group
Group type: EXPERIMENTAL
Intervention: LAVHO
Number of subjects: 48
Study 16458628 — intervention group
Group type: COMPARATOR
Intervention: VHO
Number of subjects: 48
Study 15298758 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bran flakes
Number of subjects: 21
Study 15298758 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% coconut flakes
Number of subjects: 21
Study 15298758 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% coconut flakes
Number of subjects: 21
Study 15298758 — intervention group
Group type: COMPARATOR
Intervention: Corn flakes (control)
Number of subjects: 21
Study 11783378 — intervention group
Group type: EXPERIMENTAL
Intervention: PCIA
Number of subjects: 240
Study 11783378 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA
Number of subjects: 240
Study 11783378 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 240
Study 9422301 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium 0.2 mg/kg after succinylcholine 1 mg/kg recovery to 5%
Number of subjects: 50
Study 9422301 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium 0.2 mg/kg after succinylcholine 1 mg/kg recovery to 25%
Number of subjects: 50
Study 9422301 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium 0.2 mg/kg after succinylcholine 1 mg/kg recovery to 75%
Number of subjects: 50
Study 9422301 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium 0.2 mg/kg after succinylcholine 1 mg/kg recovery to 100%
Number of subjects: 50
Study 9422301 — intervention group
Group type: COMPARATOR
Intervention: Control group (only atracurium)
Number of subjects: 50
Study 8272018 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 mg ASA
Number of subjects: 359
Study 8272018 — intervention group
Group type: COMPARATOR
Intervention: 50 mg ASA
Number of subjects: 359
Study 3305002 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (2 g per day) for 2 weeks in trial 1
Number of subjects: 0
Study 3305002 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (2 g per day) for 4 weeks in trial 2
Number of subjects: 0
Study 3305002 — intervention group
Group type: COMPARATOR
Intervention: Control (no supplementation)
Number of subjects: 0
Study 30761976 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (CRTs receiving support from a facilitator, online resources, and fidelity reviews)
Number of subjects: 375
Study 30761976 — intervention group
Group type: COMPARATOR
Intervention: Control group (CRTs receiving no additional support)
Number of subjects: 375
Study 30761976 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 375
Study 30761976 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 375
Study 29254626 — intervention group
Group type: EXPERIMENTAL
Intervention: Hollowing lumbar stabilization exercise (HLSE)
Number of subjects: 38
Study 29254626 — intervention group
Group type: EXPERIMENTAL
Intervention: Bracing lumbar stabilization exercise (BLSE)
Number of subjects: 38
Study 29254626 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 38
Study 28590364 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitopertin (10 mg)
Number of subjects: 29
Study 28590364 — intervention group
Group type: EXPERIMENTAL
Intervention: Mismatch negativity
Number of subjects: 29
Study 26073148 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 41
Study 26073148 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 41
Study 23021323 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant supported dental restoration in patients with chronic periodontal diseases (Group A)
Number of subjects: 60
Study 21060260 — intervention group
Group type: EXPERIMENTAL
Intervention: Systane
Number of subjects: 20
Study 21060260 — intervention group
Group type: EXPERIMENTAL
Intervention: Optive
Number of subjects: 20
Study 19025275 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental condition (questionnaire, plan to quit, form an implementation intention)
Number of subjects: 350
Study 19025275 — intervention group
Group type: COMPARATOR
Intervention: Active control condition (questionnaire plus instruction to plan to quit)
Number of subjects: 350
Study 19025275 — intervention group
Group type: COMPARATOR
Intervention: Passive control condition (questionnaire only)
Number of subjects: 350
Study 16880425 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant-based diet and stress management training
Number of subjects: 14
Study 12974148 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia
Number of subjects: 40
Study 12974148 — intervention group
Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 40
Study 10788945 — intervention group
Group type: EXPERIMENTAL
Intervention: Moist environment dressings for venous leg ulcers
Number of subjects: 70
Study 10788945 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment for venous leg ulcers
Number of subjects: 70
Study 10788945 — intervention group
Group type: EXPERIMENTAL
Intervention: Moist environment dressings for pressure ulcers
Number of subjects: 70
Study 10788945 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment for pressure ulcers
Number of subjects: 70
Study 8829859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 0.75 mg.kg-1
Number of subjects: 120
Study 8829859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 1.0 mg.kg-1
Number of subjects: 120
Study 8829859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 1.5 mg.kg-1
Number of subjects: 120
Study 8829859 — intervention group
Group type: COMPARATOR
Intervention: Morphine 0.1 mg.kg-1
Number of subjects: 120
Study 1340835 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin plus Metronidazole (TG)
Number of subjects: 63
Study 1340835 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PG)
Number of subjects: 63
Study 6367414 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepridil (400 mg once a day)
Number of subjects: 13
Study 6367414 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 30312434 — intervention group
Group type: EXPERIMENTAL
Intervention: CTC-positive status 2 years after chemotherapy
Number of subjects: 1087
Study 30312434 — intervention group
Group type: COMPARATOR
Intervention: CTC-negative status 2 years after chemotherapy
Number of subjects: 1087
Study 30192414 — intervention group
Group type: EXPERIMENTAL
Intervention: EHF W1 (Aptamil Pepti 1)
Number of subjects: 100
Study 30192414 — intervention group
Group type: EXPERIMENTAL
Intervention: EHF W2 (Althera)
Number of subjects: 100
Study 30192414 — intervention group
Group type: EXPERIMENTAL
Intervention: EHF C1 (Similac Alimentum)
Number of subjects: 100
Study 30192414 — intervention group
Group type: EXPERIMENTAL
Intervention: EHF C2 (Nutramigen LGG 1)
Number of subjects: 100
Study 30192414 — intervention group
Group type: COMPARATOR
Intervention: Overall expectation of better palatability
Number of subjects: 100
Study 26895988 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelatine tannate (250 mg, 4 times/day for children younger than 3 years; 500 mg, 4 times/day for children older than 3 years)
Number of subjects: 72
Study 26895988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 25311284 — intervention group
Group type: EXPERIMENTAL
Intervention: OLT (interactive, multimedia online training)
Number of subjects: 181
Study 25311284 — intervention group
Group type: COMPARATOR
Intervention: OLT+ME (OLT plus a brief, computerized motivational enhancement intervention)
Number of subjects: 181
Study 25311284 — intervention group
Group type: EXPERIMENTAL
Intervention: OLT+ME+LC (OLT+ME plus a Web‐based learning community)
Number of subjects: 181
Study 25311284 — intervention group
Group type: EXPERIMENTAL
Intervention: OLT+ME+LC
Number of subjects: 181
Study 23074247 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal OXT
Number of subjects: 70
Study 23074247 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 20151053 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg, 20 mg, 40 mg, or 80 mg based on an algorithm)
Number of subjects: 1258
Study 17702967 — intervention group
Group type: EXPERIMENTAL
Intervention: HBO2 therapy
Number of subjects: 86
Study 16178185 — intervention group
Group type: EXPERIMENTAL
Intervention: ProFile
Number of subjects: 80
Study 16178185 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper
Number of subjects: 80
Study 16178185 — intervention group
Group type: EXPERIMENTAL
Intervention: Hero 642
Number of subjects: 80
Study 16178185 — intervention group
Group type: COMPARATOR
Intervention: Stainless steel K files
Number of subjects: 80
Study 11897771 — intervention group
Group type: EXPERIMENTAL
Intervention: ETRA (SB 209670) - a dual endothelin type A/endothelin type B receptor antagonist
Number of subjects: 23
Study 11897771 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (healthy age-matched)
Number of subjects: 23
Study 11897771 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension patients
Number of subjects: 23
Study 10204835 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose (30 g)
Number of subjects: 22
Study 10204835 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (17.5 g)
Number of subjects: 22
Study 10204835 — intervention group
Group type: COMPARATOR
Intervention: Aspartame (1 g)
Number of subjects: 22
Study 7779330 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS parameters (110 Hz, 200 microseconds)
Number of subjects: 88
Study 7779330 — intervention group
Group type: COMPARATOR
Intervention: TENS parameters (50 microseconds & 4 Hz)
Number of subjects: 88
Study 7779330 — intervention group
Group type: COMPARATOR
Intervention: TENS parameters (50 microseconds & 110 Hz)
Number of subjects: 88
Study 7779330 — intervention group
Group type: COMPARATOR
Intervention: TENS parameters (200 microseconds & 4 Hz)
Number of subjects: 88
Study 1981996 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxatomide gel at 5% applied twice a day for 14 days
Number of subjects: 30
Study 1981996 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up without therapy for 14 days
Number of subjects: 30
Study 465619 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (0.25 mg/kg body weight)
Number of subjects: 15
Study 465619 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 15
Study 465619 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 15
Study 31596646 — intervention group
Group type: EXPERIMENTAL
Intervention: DLD group
Number of subjects: 234
Study 31596646 — intervention group
Group type: COMPARATOR
Intervention: TD group
Number of subjects: 234
Study 31596646 — intervention group
Group type: EXPERIMENTAL
Intervention: LTM × Group interaction
Number of subjects: 234
Study 28293966 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ACL and ALL reconstruction
Number of subjects: 110
Study 28293966 — intervention group
Group type: COMPARATOR
Intervention: Isolated ACL reconstruction
Number of subjects: 110
Study 26895002 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Warming (AW) - warmed IV fluid and lower body forced-air warmer
Number of subjects: 46
Study 26895002 — intervention group
Group type: COMPARATOR
Intervention: No Warming (NW) - blankets only
Number of subjects: 46
Study 26895002 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Warming (AW)
Number of subjects: 46
Study 26895002 — intervention group
Group type: COMPARATOR
Intervention: No Warming (NW)
Number of subjects: 46
Study 24931228 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin combined with mechanical measures
Number of subjects: 120
Study 24931228 — intervention group
Group type: COMPARATOR
Intervention: Low-molecular-weight heparin (LMWH) sodium and rivaroxaban sequentially combined with mechanical measures
Number of subjects: 120
Study 22104610 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 μg of inhaled budesonide twice per day
Number of subjects: 140
Study 22104610 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 19958872 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic interval training (AIT) at 90% of maximum heart rate, 5 d/wk, for 4 weeks
Number of subjects: 59
Study 19958872 — intervention group
Group type: COMPARATOR
Intervention: Moderate continuous training (MCT) at 70% of maximum heart rate, 5 d/wk, for 4 weeks
Number of subjects: 59
Study 19958872 — intervention group
Group type: EXPERIMENTAL
Intervention: Both AIT and MCT
Number of subjects: 59
Study 17257742 — intervention group
Group type: EXPERIMENTAL
Intervention: First screening round
Number of subjects: 1548
Study 17257742 — intervention group
Group type: EXPERIMENTAL
Intervention: Second screening round
Number of subjects: 1548
Study 15009856 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary sinus pacing (PCS leads)
Number of subjects: 24
Study 15009856 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary sinus pacing (DCS leads)
Number of subjects: 24
Study 12172328 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 2 mg / Indapamide 0.625 mg
Number of subjects: 2907
Study 12172328 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg / Indapamide 1.25 mg
Number of subjects: 2907
Study 12172328 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dosages of Perindopril and Indapamide
Number of subjects: 2907
Study 12172328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2907
Study 10431027 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention (specific details not provided)
Number of subjects: 0
Study 10431027 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 7795086 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral paste and solution containing polymyxin, gentamicin, and nystatin
Number of subjects: 61
Study 7795086 — intervention group
Group type: COMPARATOR
Intervention: Placebo paste and solution
Number of subjects: 61
Study 2094065 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-fructose-xylitol solution (GFX-B) - 10.5% solution, infused continuously for 3 days postoperatively
Number of subjects: 24
Study 2094065 — intervention group
Group type: COMPARATOR
Intervention: Sole glucose solution (PHY-3) - 10% glucose solution, infused continuously for 3 days postoperatively
Number of subjects: 24
Study 558547 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression of the calf for 5 days
Number of subjects: 128
Study 558547 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 128
Study 31872555 — intervention group
Group type: COMPARATOR
Intervention: Whole grain millet diets (0%, 20%, 40%, 60%, 80%, 100% inclusion)
Number of subjects: 540
Study 31227673 — intervention group
Group type: EXPERIMENTAL
Intervention: Real tDCS + resistance training
Number of subjects: 14
Study 31227673 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS + resistance training
Number of subjects: 14
Study 28594657 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting interspersed with 5 min light walking bouts every 30 min
Number of subjects: 34
Study 28594657 — intervention group
Group type: COMPARATOR
Intervention: Prolonged sitting
Number of subjects: 34
Study 26032878 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction/Inspiration against resistance
Number of subjects: 15
Study 23909742 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate (30 mg.kg(‐1) bolus followed by 10 mg.kg(‐1).h(‐1) continuous infusion)
Number of subjects: 70
Study 23909742 — intervention group
Group type: COMPARATOR
Intervention: Saline 0.9% (control group)
Number of subjects: 70
Study 23909742 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate
Number of subjects: 70
Study 23909742 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (magnesium and control)
Number of subjects: 70
Study 21896825 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine (MQ) 12.5 mg/kg/day for 2 days plus Artesunate (AS) 4.0 mg/kg/day for 3 days
Number of subjects: 192
Study 21896825 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 192
Study 19839251 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS) 200 microg bid
Number of subjects: 99
Study 19839251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 16102684 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (antecubital; n=15)
Number of subjects: 30
Study 16102684 — intervention group
Group type: COMPARATOR
Intervention: Group D (dorsum hand; n=15)
Number of subjects: 30
Study 16102684 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall measurements
Number of subjects: 30
Study 10624255 — intervention group
Group type: EXPERIMENTAL
Intervention: Homoeopathy treatment, details on dosage and duration not available
Number of subjects: 0
Study 10624255 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 8942578 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine infusion at a rate of 4 micrograms.kg‐1.min‐1
Number of subjects: 16
Study 8942578 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dobutamine infusion)
Number of subjects: 16
Study 1958393 — intervention group
Group type: EXPERIMENTAL
Intervention: Alizapride (16 mg/kg) alone
Number of subjects: 21
Study 1958393 — intervention group
Group type: EXPERIMENTAL
Intervention: Alizapride (16 mg/kg) + Dexamethasone (40 mg)
Number of subjects: 21
Study 1958393 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (4 mg/kg) + Dexamethasone (40 mg)
Number of subjects: 21
Study 6807152 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 ppm ozone
Number of subjects: 13
Study 6807152 — intervention group
Group type: COMPARATOR
Intervention: Air (control)
Number of subjects: 13
Study 30799142 — intervention group
Group type: EXPERIMENTAL
Intervention: Novartis Access (intervention)
Number of subjects: 639
Study 30104294 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 units/mL (Gla‐300)
Number of subjects: 929
Study 30104294 — intervention group
Group type: COMPARATOR
Intervention: Insulin degludec 100 units/mL (IDeg‐100)
Number of subjects: 929
Study 27159857 — intervention group
Group type: EXPERIMENTAL
Intervention: Superpulsed low level laser therapy (SLLLT) at T0, 24 hours, and 48 hours with a GaAs laser diode
Number of subjects: 25
Study 27159857 — intervention group
Group type: COMPARATOR
Intervention: Control site (no SLLLT treatment)
Number of subjects: 25
Study 24121243 — intervention group
Group type: EXPERIMENTAL
Intervention: Active video games (AVG) using a Wii Nintendo console with the game Wii Fit Plus for 40 days
Number of subjects: 34
Study 24121243 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study 22894891 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga classes (hatha yoga) held twice a week for 10 weeks
Number of subjects: 27
Study 22894891 — intervention group
Group type: COMPARATOR
Intervention: Control group (no yoga classes)
Number of subjects: 27
Study 19639858 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored e-mail messages based on participants' identified needs
Number of subjects: 73
Study 19639858 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no tailored e-mail messages)
Number of subjects: 73
Study 17617554 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSeal laryngeal mask airway
Number of subjects: 200
Study 15035240 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental positioning and distraction
Number of subjects: 43
Study 15035240 — intervention group
Group type: COMPARATOR
Intervention: Control group (comparison)
Number of subjects: 43
Study 12685875 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin monotherapy (n = 8)
Number of subjects: 14
Study 12685875 — intervention group
Group type: COMPARATOR
Intervention: Insulin plus glibenclamide (n = 6)
Number of subjects: 14
Study 9655776 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat cold-water immersion (2 hours in 20 degrees C water, three times a day)
Number of subjects: 8
Study 9655776 — intervention group
Group type: COMPARATOR
Intervention: Single cold-water immersion (Control)
Number of subjects: 8
Study 7661746 — intervention group
Group type: COMPARATOR
Intervention: Body mass index < 22
Number of subjects: 17764
Study 7661746 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index 22 to < 25
Number of subjects: 17764
Study 7661746 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index 25 to < 27.8
Number of subjects: 17764
Study 7661746 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index 27.8 or more
Number of subjects: 17764
Study 7661746 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in body mass index by 2 units
Number of subjects: 17764
Study 7661746 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher body mass index
Number of subjects: 17764
Study 30183453 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurac vibration during side-lying bridge exercise
Number of subjects: 30
Study 30183453 — intervention group
Group type: COMPARATOR
Intervention: Side-lying bridge exercise without Neurac vibration
Number of subjects: 30